These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6149986

  • 1. [Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias].
    Ishii M, Komori S, Satoh H, Ohta T, Motomura S, Hashimoto K.
    Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):259-66. PubMed ID: 6149986
    [Abstract] [Full Text] [Related]

  • 2. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS, Seth SD, Manchanda SC, Nayar U.
    Arch Int Pharmacodyn Ther; 1989 Sep; 302():128-44. PubMed ID: 2636814
    [Abstract] [Full Text] [Related]

  • 3. Antiarrhythmic effects of L-penbutolol and DL-propranolol. Comparison of the effects of these two drugs on conductivity and excitability in canine heart in vivo.
    Yamada K, Toyama J, Nimi N, Sugenoya J, Ohno M, Sugiyama S.
    Jpn Heart J; 1979 Sep; 20(5):603-11. PubMed ID: 501926
    [Abstract] [Full Text] [Related]

  • 4. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias.
    Wu KM, Proakis AG, Hunter TL, Shanklin JR.
    Arch Int Pharmacodyn Ther; 1989 Sep; 301():131-50. PubMed ID: 2624512
    [Abstract] [Full Text] [Related]

  • 5. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
    Gibson JK, Gelband H, Bassett AL.
    J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
    [Abstract] [Full Text] [Related]

  • 6. Association of in vivo and in vitro propranolol levels in canine Purkinje fibers with antiarrhythmic effects.
    Pruett JK, Walle T, Bagwell EE.
    J Pharmacol Exp Ther; 1977 Jul; 202(1):45-54. PubMed ID: 17729
    [Abstract] [Full Text] [Related]

  • 7. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL, Sulkowski T, Much DR, Wendt RL.
    Arzneimittelforschung; 1983 Jul; 33(9):1258-68. PubMed ID: 6685506
    [Abstract] [Full Text] [Related]

  • 8. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome.
    Shimizu W, Ohe T, Kurita T, Kawade M, Arakaki Y, Aihara N, Kamakura S, Kamiya T, Shimomura K.
    J Am Coll Cardiol; 1995 Nov 01; 26(5):1299-309. PubMed ID: 7594047
    [Abstract] [Full Text] [Related]

  • 9. [Arrhythmias. 7. Treatment with beta-receptor blocking agents].
    Johnsson G, Persson S.
    Lakartidningen; 1971 Jun 14; 68():Suppl II:100-. PubMed ID: 4398809
    [No Abstract] [Full Text] [Related]

  • 10. Haemodynamic and electrophysiological acute toxic effects of mercury in anaesthetized rats and in langendorff perfused rat hearts.
    Massaroni L, Rossoni LV, Amaral SM, Stefanon I, Oliveira EM, Vassallo DV.
    Pharmacol Res; 1995 Jun 14; 32(1-2):27-36. PubMed ID: 8668644
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y, Kawada M, Sawanobori K, Sonoki H, Inoue K, Mizuno K, Itou T, Tabunoki Y, Tsukamoto M, Ohashi Y, Kyotani Y, Shimizu N, Fujii M, Nakamura M.
    Arzneimittelforschung; 1998 Mar 14; 48(3):219-31. PubMed ID: 9553677
    [Abstract] [Full Text] [Related]

  • 12. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML, Stone CA, Wenger HC, Evans R, Lagerquist B, O'Malley T.
    J Pharmacol Exp Ther; 1975 Aug 14; 194(2):415-26. PubMed ID: 1151767
    [Abstract] [Full Text] [Related]

  • 13. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I, Hashimoto K, Katano Y, Tsukada T, Matsuda H.
    Nihon Yakurigaku Zasshi; 1976 Jul 14; 72(5):557-71. PubMed ID: 11153
    [Abstract] [Full Text] [Related]

  • 14. Antiarrhythmic plasma concentrations of cibenzoline on canine ventricular arrhythmias.
    Hashimoto K, Akiyama K, Mitsuhashi H.
    J Cardiovasc Pharmacol; 1987 Feb 14; 9(2):148-53. PubMed ID: 2435991
    [Abstract] [Full Text] [Related]

  • 15. Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction.
    Lynch JJ, Wallace AA, Stump GL, Stupienski RF, Kothstein T, Gehret JR.
    J Pharmacol Exp Ther; 1996 May 14; 277(2):671-8. PubMed ID: 8627544
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models.
    Komori S, Ishii M, Hashimoto K.
    Jpn J Pharmacol; 1985 May 14; 38(1):73-82. PubMed ID: 4021230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.